Liu, D., J. E. Shoag, D. Poliak, R. S. Goueli, V. Ravikumar, D. Redmond, A. Vosoughi, et al. 2020. Integrative Multiplatform Molecular Profiling of Benign Prostatic Hyperplasia Identifies Distinct Subtypes.
Publications
2020
2019
Wu, S., S. X. Lin, G. J. Wirth, M. Lu, J. Lu, A. O. Subtelny, Z. Wang, D. M. Dahl, A. F. Olumi, and C. L. Wu. 2019. Impact of Multifocality and Multilocation of Positive Surgical Margin After Radical Prostatectomy on Predicting Oncological Outcome.
Wu, S., X. Lin, S. X. Lin, M. Lu, T. Deng, Z. Wang, A. F. Olumi, et al. 2019. Impact of Biopsy Perineural Invasion on the Outcomes of Patients Who Underwent Radical Prostatectomy: A Systematic Review and Meta-Analysis.
Burns, R. B., A. F. Olumi, D. K. Owens, and G. W. Smetana. 2019. Would You Recommend Prostate-Specific Antigen Screening for This Patient?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
Wu, S., S. X. Lin, M. Lu, A. O. Subtelny, Z. Wang, D. M. Dahl, A. F. Olumi, and C. L. Wu. 2019. Assessment of 5-Year Overall Survival in Bladder Cancer Patients With Incidental Prostate Cancer Identified at Radical Cystoprostatectomy.
2018
Yun, H., R. Bedolla, A. Horning, R. Li, H. C. Chiang, T. H. Huang, R. Reddick, A. F. Olumi, R. Ghosh, and A. P. Kumar. 2018. BRCA1 Interacting Protein COBRA1 Facilitates Adaptation to Castrate-Resistant Growth Conditions.
Tao, Z., L. D. Zheng, C. Smith, J. Luo, A. Robinson, F. A. Almeida, Z. Wang, A. F. Olumi, D. Liu, and Z. Cheng. 2018. Estradiol Signaling Mediates Gender Difference in Visceral Adiposity via Autophagy.
Wu, S., J. Ye, Z. Wang, S. X. Lin, M. Lu, Y. Liang, X. Zhu, A. F. Olumi, W. D. Zhong, and C. L. Wu. 2018. Expression of Aromatase in Tumor Related Stroma Is Associated With Human Bladder Cancer Progression.
Wang, Z., and A. F. Olumi. 2018. Metformin: an Antiproliferative Agent and Methylation Regulator in Treating Prostatic Disease?.
Vandergrift, L. A., E. A. Decelle, J. Kurth, S. Wu, T. L. Fuss, E. M. DeFeo, E. F. Halpern, et al. 2018. Metabolomic Prediction of Human Prostate Cancer Aggressiveness: Magnetic Resonance Spectroscopy of Histologically Benign Tissue.